Synergy of Caspofungin with Human Polymorphonuclear Granulocytes for Killing <i>Candida albicans</i>

Viviana Cristina Tullio, Narcisa Mandras, Daniela Scalas, Valeria Allizond, Giuliana Banche, Janira Roana, Deborah S. Greco, Franco Castagno, Annamaria Cuffini, Nicola Carlone

Antimicrobial Agents and Chemotherapy · 2010 · 17 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

The influence of caspofungin on polymorphonuclear leukocyte (PMN) phagocytosis and intracellular killing of Candida albicans was investigated. Caspofungin, at all of the concentrations tested (2, 3.2, and 8 microg/ml), significantly increased intracellular killing by PMNs through its direct action on both yeast cells and PMNs, indicating the potential ability of caspofungin to synergize with phagocytes for candidal killing. Caspofungin may therefore constitute an effective therapeutic option for the treatment of invasive fungal infections, including those refractory to conventional treatment with azole agents.

References

14